This week, the FDA gave the go-ahead for Moderna and Pfizer to update their respective mRNA vaccines, which will be tuned to combat the latest variants.
A new analysis from the Commonwealth Fund predicts that even a modest booster campaign would save tens of thousands of lives and billions in medical costs.
The new generation of boosters, which protect against the latest Omicron variants as well as the original coronavirus, will likely be available within weeks.
Second covid-19 boosters for the general population are reportedly being postponed in favor of new and improved shots.
The FDA says children between 5 and 11 years old can now receive a third shot of the Pfizer vaccine.
The U.S. has seen a decline in cases but nobody knows how long that will last.
An annual covid-19 vaccination in the same vein as the yearly flu vaccine is also being reviewed.
Employees will be required to show proof that they’ve gotten their booster shot or take an antigen test to enter Apple premises.
The 99-year-old actress didn't die from an adverse reaction to a covid-19 booster.
A low-cost, effective vaccine authorized for use in India this week could soon be shared around the world.
The man was in his 50s and had been previously infected, but he was unvaccinated and had underlying health conditions
The fast-spreading Omicron variant appears to behave slightly differently than earlier strains.
Both Senators have been vaccinated and had booster shots.
The UK Health Secretary warned "we've never seen this kind of growth before."
Preliminary studies are finding that vaccines may not provide as much protection from Omicron, but hybrid or boosted immunity may remain robust.
The data is clear by now: Booster doses are providing high levels of protection against the misery caused by the coronavirus.
Psaki didn't travel with President Biden to Europe for COP26.
For those who need boosters, the mix-and-match approach with the various vaccines seems to be safe and effective.
High-risk Americans and those over 65 are being told to get boosters, while J&J recipients should get any shot they want two months after their original dose.
The panel agreed that people over 65 and high-risk groups who took the original Moderna vaccine should be able to get a half-strength booster.